SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Director/PDMR Shareholding

5 Oct 2009 16:54

RNS Number : 2650A
Consort Medical PLC
05 October 2009
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

1.

Name of the issuer

CONSORT MEDICAL PLC

2.

State whether the notification relates to (i) a transaction notified in accordance with DR3.1.4R(1)(a); or

(ii) DR3.1.1(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328)

of the Companies Act 1985; or

(iii) both (i) and (ii)

BOTH

3.

Name of person discharging managerial responsibilities/director

Jon Glenn, Director

Toby Woolrych, Director

Joe Barry, PDMR

Don Dumoulin, PDMR

Lisa King, PDMR

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person.

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest.

THE NOTIFICATION IS IN RESPECT OF HOLDINGS OF THE PERSONS REFERRED TO

IN 3 ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares.

N/A

7.

Name of registered shareholder(s) and, if more than one, the number of shares held by each of them.

N/A

8.

State the nature of the transaction.

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired.

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage).

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed.

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage).

N/A

13.

Price per share or value of transaction.

N/A

14.

Date and place of transaction.

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage).

N/A

16.

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes.

N/A

17.

Date of grant.

2 October 2009

18.

Period during which or date on which it can be exercised.

1 October 2012 provided the applicable performance criteria have been satisfied.

19.

Total amount paid (if any) for grant of the option.

NIL

20.

Description of shares or debentures involved (class and number).

Grant of Performance Shares under the Bespak plc 2005 LTIP in respect of ordinary 10p shares as

follows:

Name

Status

Performance Shares

Jonathan Glenn

Director

77,647

Toby Woolrych

Director

47,059

Joe Barry

PDMR

26,471

Lisa King

PDMR

28,235

Don Dumoulin

PDMR

41,386

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise.

£4.25

22.

Total number of shares or debentures over which options held following notification.

Name

Status

Performance Shares

Jonathan Glenn

Director

153,230

Toby Woolrych

Director

84,848

Joe Barry

Director

54,747

Lisa King

Director

47,115

Don Dumoulin

Director

81,169

23.

Any additional information.

NONE

24.

Name of contact and telephone number for queries.

Robert Allnutt

Company Secretary

01442 867924

Name and signature of duly authorised officer or issuer responsible for making notification.

Robert Allnutt

Date of Notification

5 October 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEELFBKBBZFBQ
Date   Source Headline
1st Nov 20179:35 amRNSDirector/PDMR Shareholding
1st Nov 20179:04 amRNSTotal Voting Rights
16th Oct 20179:42 amRNSBlock listing Interim Review
11th Oct 20172:10 pmRNSDirector/PDMR Shareholding
11th Oct 201711:38 amRNSHolding(s) in Company
2nd Oct 201710:03 amRNSTotal Voting Rights
11th Sep 20175:15 pmRNSDirector/PDMR Shareholding
7th Sep 20171:56 pmRNSDirector/PDMR Shareholding
6th Sep 20174:35 pmRNSResult of AGM
1st Sep 20172:47 pmRNSDirector Declaration
10th Aug 20178:38 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20173:48 pmRNSPosting of Annual Financial Report and AGM Notice
26th Jul 20179:22 amRNSDirector/PDMR Shareholding
20th Jul 20178:07 amRNSAdditional Listing
11th Jul 20178:53 amRNSDirector/PDMR Shareholding
21st Jun 201712:10 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
15th Jun 20177:00 amRNSFull year results
5th Jun 201710:09 amRNSDirector Declaration
8th May 20177:00 amRNSNotice of Results
2nd May 201711:10 amRNSTotal Voting Rights
27th Apr 201711:51 amRNSResult of General Meeting
18th Apr 20179:36 amRNSBlock listing Interim Review
3rd Apr 20179:49 amRNSNotice of GM
1st Mar 20179:22 amRNSTotal Voting Rights
30th Jan 201712:44 pmRNSHolding(s) in Company
26th Jan 20172:59 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSParticipation in equity raise for Atlas Genetics
3rd Jan 20177:00 amRNSVoke® (DEV200) update
15th Dec 20169:45 amRNSHolding(s) in Company
14th Dec 201610:35 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSDirectorate Change
9th Dec 20163:18 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSInterim Results
2nd Dec 20169:25 amRNSHolding(s) in Company
1st Dec 20169:43 amRNSTotal Voting Rights
25th Nov 20167:00 amRNSCFO Appointment
8th Nov 20161:24 pmRNSDirector/PDMR Shareholding
1st Nov 201610:15 amRNSTotal Voting Rights
31st Oct 20163:32 pmRNSDirector/PDMR Shareholding
31st Oct 20161:00 pmRNSNotice of Results
27th Oct 20167:00 amRNSCIMZIA® AutoClicks® prefilled pen launched in UK
14th Oct 201610:02 amRNSBlock listing Interim Review
14th Oct 20167:00 amRNSAnnouncement of master development agreement
11th Oct 201612:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20169:00 amRNSTotal Voting Rights
19th Sep 20169:47 amRNSBespak Technology in UCB PrefilledPen EMA Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.